›Publications›Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations. Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations. Auteurs : Dantoing E, Piton N, Salaün M, Thiberville L, Guisier F. Revue : Int J Mol Sci. Année : 2021 Groupe : QuantIF ← Retour aux publications